Psyllid ID: psy17031


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------42
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYPPTHASASLSGASASLSGAGKSQQDAMLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR
ccHHHHHHHHHHHHHHccHHEEEHHEEcccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHcHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHEEcccccccccccccccccccccEEEEccHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHcEEEEEEccccccccccHHHHHHHHHHHHHHHHHHcEEEEEEEEEEccEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccEEEEEcccHHHHHHHHHHHcccccccHHHHHHHHHHHHHcccccHHHHHHHHcccccccc
ccHHHHHHHHHHHHHHcccEEEEEEEccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEccccccccHHHHHHHHHHHHHHHHHHHccEEEEEEEEEccccEEEEcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHcccccEEHHEcccHHccc
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRvsarnyppthasaslsgasaslsgagksqqdamltwspirtltklnTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYaikypmnfcgsckYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYaikypmnfcgSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQvygyiprtqNYIAVATLIQSlaplnsaanpIIYCIFRTGNNNR
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYPPTHASASLSGASASLSGAGKSQQDAMLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSsvtwkagntackvvrysqavVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRssvtwkagntackvvrysqavVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYPPTHasaslsgasaslsgagKSQQDAMLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAViisicyiliittiWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR
***FVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSA*****************************MLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRT*****
*EQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYP******************************PIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNN**
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYPP***********************AMLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARN*********************************IRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTG****
ooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiii
iiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiii
ooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooo
oooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiii
SSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVAVTRVSARNYPPTHASASLSGASASLSGAGKSQQDAMLTWSPIRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query419 2.2.26 [Sep-21-2011]
Q868T3506 Cardioacceleratory peptid yes N/A 0.565 0.468 0.501 7e-73
Q8BZP8371 Neuropeptide S receptor O yes N/A 0.494 0.557 0.4 2e-44
Q6W5P4371 Neuropeptide S receptor O yes N/A 0.522 0.590 0.396 8e-44
P0C0L6372 Neuropeptide S receptor O yes N/A 0.486 0.548 0.403 8e-44
Q56H79371 Neuropeptide S receptor O yes N/A 0.522 0.590 0.389 1e-43
Q2V2K5 407 Gonadotropin-releasing ho N/A N/A 0.362 0.373 0.384 8e-23
O77808370 Vasopressin V2 receptor O no N/A 0.558 0.632 0.292 6e-21
P32307370 Vasopressin V2 receptor O no N/A 0.470 0.532 0.296 1e-20
Q90352 434 [Arg8]-vasotocin receptor N/A N/A 0.477 0.460 0.269 4e-20
Q90252389 Mesotocin receptor OS=Buf N/A N/A 0.539 0.580 0.277 6e-20
>sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster GN=CcapR PE=2 SV=3 Back     alignment and function desciption
 Score =  275 bits (702), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 139/277 (50%), Positives = 180/277 (64%), Gaps = 40/277 (14%)

Query: 176 VVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGN 235
           V+   ++ VL  + I++    K  MN+      + DLCVG+L+VLTDI+WR +++W+AGN
Sbjct: 136 VIVLGNSAVLFVMFINKNR--KSRMNYFIKQLALADLCVGLLNVLTDIIWRITISWRAGN 193

Query: 236 TACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILS 295
            ACK +R+SQ  VTYSSTYVLVA+SIDRY AI +PMNF  SW+RAR LV  AWLIS + S
Sbjct: 194 LACKAIRFSQVCVTYSSTYVLVAMSIDRYDAITHPMNFSKSWKRARHLVAGAWLISALFS 253

Query: 296 IPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVIISICYILIITTIWA 355
           +PI VL+  +L+QG  QCWIE   P  WQ+YMSLV+  LF IPA+IIS CY +I+ TIWA
Sbjct: 254 LPILVLYEEKLIQGHPQCWIELGSPIAWQVYMSLVSATLFAIPALIISACYAIIVKTIWA 313

Query: 356 KSKL--------------------------------------YTFVLCWSPYIVFDLLQV 377
           K  +                                      + F++CWSPYI+FDLLQV
Sbjct: 314 KGSIFVPTERAGFGAAPARRASSRGIIPRAKVKTVKMTLTIVFVFIICWSPYIIFDLLQV 373

Query: 378 YGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRT 414
           +G IP +Q  IA+AT IQSLAPLNSAANP+IYC+F +
Sbjct: 374 FGQIPHSQTNIAIATFIQSLAPLNSAANPLIYCLFSS 410




Binds to the cardioacceleratory peptide, which is a neuropeptide.
Drosophila melanogaster (taxid: 7227)
>sp|Q8BZP8|NPSR1_MOUSE Neuropeptide S receptor OS=Mus musculus GN=Npsr1 PE=2 SV=1 Back     alignment and function description
>sp|Q6W5P4|NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 Back     alignment and function description
>sp|P0C0L6|NPSR1_RAT Neuropeptide S receptor OS=Rattus norvegicus GN=Npsr1 PE=2 SV=1 Back     alignment and function description
>sp|Q56H79|NPSR1_MACMU Neuropeptide S receptor OS=Macaca mulatta GN=NPSR1 PE=2 SV=1 Back     alignment and function description
>sp|Q2V2K5|GNRHR_OCTVU Gonadotropin-releasing hormone receptor OS=Octopus vulgaris GN=GNRHR PE=2 SV=1 Back     alignment and function description
>sp|O77808|V2R_CANFA Vasopressin V2 receptor OS=Canis familiaris GN=AVPR2 PE=2 SV=1 Back     alignment and function description
>sp|P32307|V2R_PIG Vasopressin V2 receptor OS=Sus scrofa GN=AVPR2 PE=2 SV=1 Back     alignment and function description
>sp|Q90352|AVT_CATCO [Arg8]-vasotocin receptor OS=Catostomus commersonii PE=2 SV=1 Back     alignment and function description
>sp|Q90252|MTR_BUFMA Mesotocin receptor OS=Bufo marinus PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query419
403182979326 AAEL008652-PA, partial [Aedes aegypti] 0.656 0.843 0.465 2e-73
170039713437 cardioacceleratory peptide receptor [Cul 0.565 0.542 0.534 3e-72
328713510405 PREDICTED: cardioacceleratory peptide re 0.544 0.562 0.521 4e-72
195453795502 GK14383 [Drosophila willistoni] gi|19417 0.520 0.434 0.531 1e-71
194743714 539 GF18226 [Drosophila ananassae] gi|190627 0.486 0.378 0.549 1e-71
270008192336 hypothetical protein TcasGA2_TC013945, p 0.563 0.702 0.545 2e-71
321470703345 hypothetical protein DAPPUDRAFT_317355 [ 0.546 0.663 0.530 3e-71
195389602501 GJ23325 [Drosophila virilis] gi|19415155 0.486 0.407 0.545 3e-71
195349581506 GM10207 [Drosophila sechellia] gi|194123 0.565 0.468 0.501 4e-71
90110012506 RecName: Full=Cardioacceleratory peptide 0.565 0.468 0.501 4e-71
>gi|403182979|gb|EAT39546.2| AAEL008652-PA, partial [Aedes aegypti] Back     alignment and taxonomy information
 Score =  282 bits (721), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 169/363 (46%), Positives = 208/363 (57%), Gaps = 88/363 (24%)

Query: 95  TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVW 154
           TEQF +LW LFI+IVLGN AV+ TL     R+SRMNFFI  LA+ADL VG+LSVLTDIV 
Sbjct: 1   TEQFAVLWILFIVIVLGNLAVLVTLFMNKNRKSRMNFFIKQLAIADLSVGLLSVLTDIVQ 60

Query: 155 RSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCV 214
           R +++W AGN ACKV+R+ Q  VTY+STYVLVALSIDRY AI +PMNF G CK+     V
Sbjct: 61  RITISWLAGNVACKVIRFIQVWVTYASTYVLVALSIDRYDAITHPMNFSGCCKFDAMPMV 120

Query: 215 GVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFC 274
            +  VL++                                    +SI+  +         
Sbjct: 121 LLRPVLSE-----------------------------------KISIESVF--------- 136

Query: 275 GSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALAL 334
            + +RAR LVG AW  S I S P+  L+  R++Q   QCWI+     +WQLYM  VA +L
Sbjct: 137 -NRKRARRLVGAAWGFSAIFSSPMFYLYEERVIQDQLQCWIDLGNALRWQLYMCWVATSL 195

Query: 335 FVIPAVIISICYILIITTIWA---------------------------------KSKLYT 361
           FVIPA IIS CY++II TIW+                                 K+K+ T
Sbjct: 196 FVIPAFIISACYVIIIKTIWSKGSVLGPVGGKYRYRNGSAELARRRASSRGIIPKAKVKT 255

Query: 362 ----------FVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCI 411
                     FVLCWSPYIVFDLLQV+  IP+TQ  IA+AT IQSLAPLNSAANP+IYC+
Sbjct: 256 VKMTIVIVIVFVLCWSPYIVFDLLQVFEQIPKTQTNIAIATFIQSLAPLNSAANPLIYCL 315

Query: 412 FRT 414
           F T
Sbjct: 316 FST 318




Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170039713|ref|XP_001847670.1| cardioacceleratory peptide receptor [Culex quinquefasciatus] gi|167863294|gb|EDS26677.1| cardioacceleratory peptide receptor [Culex quinquefasciatus] Back     alignment and taxonomy information
>gi|328713510|ref|XP_003245097.1| PREDICTED: cardioacceleratory peptide receptor-like [Acyrthosiphon pisum] Back     alignment and taxonomy information
>gi|195453795|ref|XP_002073946.1| GK14383 [Drosophila willistoni] gi|194170031|gb|EDW84932.1| GK14383 [Drosophila willistoni] Back     alignment and taxonomy information
>gi|194743714|ref|XP_001954345.1| GF18226 [Drosophila ananassae] gi|190627382|gb|EDV42906.1| GF18226 [Drosophila ananassae] Back     alignment and taxonomy information
>gi|270008192|gb|EFA04640.1| hypothetical protein TcasGA2_TC013945, partial [Tribolium castaneum] Back     alignment and taxonomy information
>gi|321470703|gb|EFX81678.1| hypothetical protein DAPPUDRAFT_317355 [Daphnia pulex] Back     alignment and taxonomy information
>gi|195389602|ref|XP_002053465.1| GJ23325 [Drosophila virilis] gi|194151551|gb|EDW66985.1| GJ23325 [Drosophila virilis] Back     alignment and taxonomy information
>gi|195349581|ref|XP_002041321.1| GM10207 [Drosophila sechellia] gi|194123016|gb|EDW45059.1| GM10207 [Drosophila sechellia] Back     alignment and taxonomy information
>gi|90110012|sp|Q868T3.3|CCAPR_DROME RecName: Full=Cardioacceleratory peptide receptor gi|60729595|pir||JC7952 crustacean cardioactive peptide receptor (CG6111) - fruit fly (Drosophila melanogaster) gi|29169183|gb|AAO66429.1| CCAP receptor [Drosophila melanogaster] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query419
FB|FBgn0039396 506 CcapR "Cardioacceleratory pept 0.436 0.361 0.502 1.6e-67
RGD|1564154372 Npsr1 "neuropeptide S receptor 0.400 0.451 0.405 7.9e-55
MGI|MGI:2441738371 Npsr1 "neuropeptide S receptor 0.400 0.452 0.408 1e-54
UNIPROTKB|F1MJZ0370 NPSR1 "Uncharacterized protein 0.400 0.454 0.408 2.6e-54
UNIPROTKB|Q6W5P4371 NPSR1 "Neuropeptide S receptor 0.400 0.452 0.414 4.2e-54
UNIPROTKB|E1BUZ1373 NPSR1 "Uncharacterized protein 0.508 0.571 0.357 3.7e-44
UNIPROTKB|F1Q0I5302 NPSR1 "Uncharacterized protein 0.381 0.529 0.413 9.6e-44
UNIPROTKB|F1SIK6297 NPSR1 "Uncharacterized protein 0.372 0.525 0.414 1.2e-43
UNIPROTKB|F1NV74370 AVPR2 "Uncharacterized protein 0.310 0.351 0.320 1e-25
UNIPROTKB|Q5WA50 426 CTR2 "Cephalotocin receptor 2" 0.350 0.345 0.313 3e-25
FB|FBgn0039396 CcapR "Cardioacceleratory peptide receptor" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 479 (173.7 bits), Expect = 1.6e-67, Sum P(2) = 1.6e-67
 Identities = 93/185 (50%), Positives = 123/185 (66%)

Query:   176 VVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGN 235
             V+   ++ VL  + I++    K  MN+      + DLCVG+L+VLTDI+WR +++W+AGN
Sbjct:   136 VIVLGNSAVLFVMFINKNR--KSRMNYFIKQLALADLCVGLLNVLTDIIWRITISWRAGN 193

Query:   236 TACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILS 295
              ACK +R+SQ  VTYSSTYVLVA+SIDRY AI +PMNF  SW+RAR LV  AWLIS + S
Sbjct:   194 LACKAIRFSQVCVTYSSTYVLVAMSIDRYDAITHPMNFSKSWKRARHLVAGAWLISALFS 253

Query:   296 IPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVXXXXXXXXXXXXXWA 355
             +PI VL+  +L+QG  QCWIE   P  WQ+YMSLV+  LF IPA+             WA
Sbjct:   254 LPILVLYEEKLIQGHPQCWIELGSPIAWQVYMSLVSATLFAIPALIISACYAIIVKTIWA 313

Query:   356 KSKLY 360
             K  ++
Sbjct:   314 KGSIF 318


GO:0016021 "integral to membrane" evidence=IEA;ISS
GO:0005000 "vasopressin receptor activity" evidence=IEA;ISS
GO:0007186 "G-protein coupled receptor signaling pathway" evidence=IEA;ISS;NAS
GO:0008188 "neuropeptide receptor activity" evidence=ISS;IDA;NAS
GO:0001653 "peptide receptor activity" evidence=IDA
GO:0005887 "integral to plasma membrane" evidence=ISS
GO:0018990 "ecdysis, chitin-based cuticle" evidence=TAS
RGD|1564154 Npsr1 "neuropeptide S receptor 1" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
MGI|MGI:2441738 Npsr1 "neuropeptide S receptor 1" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|F1MJZ0 NPSR1 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|Q6W5P4 NPSR1 "Neuropeptide S receptor" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|E1BUZ1 NPSR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1Q0I5 NPSR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1SIK6 NPSR1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|F1NV74 AVPR2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|Q5WA50 CTR2 "Cephalotocin receptor 2" [Octopus vulgaris (taxid:6645)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
Q868T3CCAPR_DROMENo assigned EC number0.50180.56560.4683yesN/A

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query419
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 6e-26
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 4e-12
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 1e-11
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 2e-07
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 8e-06
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 2e-05
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 8e-04
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
 Score =  105 bits (263), Expect = 6e-26
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 29/228 (12%)

Query: 211 DLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYP 270
           DL   +      + +     W  G+  CK+V +   V  Y+S  +L A+SIDRY AI +P
Sbjct: 24  DLLFLLTLPPWALYYLVGGDWPFGDALCKLVGFLFVVNGYASILLLTAISIDRYLAIVHP 83

Query: 271 M--NFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQ--CWIEFEKPWQWQLY 326
           +      + RRA+ L+ + W+++ +LS+P  +   +R V+  +   C I+F +    + Y
Sbjct: 84  LRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTVEEGNVTTCLIDFPEESTKRSY 143

Query: 327 MSLVALALFVIPAVIISICYILIITTIWAKSKLY-------------------------T 361
             L  L  FV+P ++I +CY LI+ T+  +++                            
Sbjct: 144 TLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGASQARAKRSSSKERKAAKMLLVVVVV 203

Query: 362 FVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIY 409
           FVLCW PY +  LL     +   +       +   LA +NS  NPIIY
Sbjct: 204 FVLCWLPYHIVLLLDSLCPLSIWRLLPTALLITLWLAYVNSCLNPIIY 251


This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251

>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 419
KOG4219|consensus423 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
KOG4220|consensus 503 99.97
PHA02638417 CC chemokine receptor-like protein; Provisional 99.97
PHA03087335 G protein-coupled chemokine receptor-like protein; 99.97
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 99.94
KOG2087|consensus363 99.86
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.66
PHA03234338 DNA packaging protein UL33; Provisional 99.63
PHA03235409 DNA packaging protein UL33; Provisional 99.45
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.42
PHA02638417 CC chemokine receptor-like protein; Provisional 99.4
PHA02834323 chemokine receptor-like protein; Provisional 99.39
PHA03087335 G protein-coupled chemokine receptor-like protein; 99.32
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.01
KOG2087|consensus363 98.92
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 98.88
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 98.81
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 98.8
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 98.77
KOG4219|consensus423 98.23
PF11710201 Git3: G protein-coupled glucose receptor regulatin 98.2
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 98.09
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 98.01
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 97.84
KOG4220|consensus503 97.72
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 97.71
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 97.57
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 97.46
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 97.36
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 96.96
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 96.86
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 96.46
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 96.38
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 95.96
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 95.69
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 95.13
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 93.94
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 91.86
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 90.85
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 89.54
KOG4193|consensus610 87.69
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 87.4
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 85.04
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 83.64
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 81.54
>KOG4219|consensus Back     alignment and domain information
Probab=100.00  E-value=4.1e-38  Score=298.31  Aligned_cols=261  Identities=23%  Similarity=0.441  Sum_probs=215.6

Q ss_pred             cccccccchHHHHHHHHHHHHHHhhhheeeEEeEecccccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccc
Q psy17031         87 IRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTA  166 (419)
Q Consensus        87 ~~~~~~~~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~  166 (419)
                      ...+........+++..+.+++++||+++++++..+|++|+.+|+|+.|||+||+.++++..++.........|.+|+.+
T Consensus        28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal~~~W~~G~f~  107 (423)
T KOG4219|consen   28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYALHQEWYFGSFY  107 (423)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHHHhccccccce
Confidence            34444455566788889999999999999999999999999999999999999999999999999999888999999999


Q ss_pred             eeeeeeeceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHH
Q psy17031        167 CKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQA  246 (419)
Q Consensus       167 C~~~~~~~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~  246 (419)
                      |+++.|+......+|+++|+|||+|||+||.||+                                              
T Consensus       108 C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl----------------------------------------------  141 (423)
T KOG4219|consen  108 CRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPL----------------------------------------------  141 (423)
T ss_pred             eeeccccchhhhhHhHHHHHHHHHHHHHHHhhhc----------------------------------------------
Confidence            9999998888888888888888877777777664                                              


Q ss_pred             HHHHHHHHHHHHHHHhhheeeeccccccccchhhhHHHHHHHHHHHHHHHHHHHhheeEeecC-----CCceeeccccc-
Q psy17031        247 VVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQG-----TSQCWIEFEKP-  320 (419)
Q Consensus       247 ~~~~~s~~~l~~i~~~Ry~~i~~p~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~-----~~~C~~~~~~~-  320 (419)
                                               +.+.++|...+.+.++|+++++++.|..........+.     ...|...++++ 
T Consensus       142 -------------------------~~r~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~~~~~~~~~pe~~  196 (423)
T KOG4219|consen  142 -------------------------QPRPSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGESRVVCVTAWPEHV  196 (423)
T ss_pred             -------------------------ccCCCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcceEEEEEeccccc
Confidence                                     44557888889999999999999999999877665543     45565555443 


Q ss_pred             ----hhH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCc-------------------------eEEEEEechh
Q psy17031        321 ----WQW---QLYMSLVALALFVIPAVIISICYILIITTIWAKSK-------------------------LYTFVLCWSP  368 (419)
Q Consensus       321 ----~~~---~~~~~~~~~~~~~vp~~ii~~~y~~i~~~l~~~~~-------------------------~~~f~~cw~P  368 (419)
                          ...   +.|.....++.+++|++++...|..|.+++|+++.                         ++.|.+||+|
T Consensus       197 ~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~~d~~~~~~kak~K~vkmliiVV~~FaicWlP  276 (423)
T KOG4219|consen  197 CPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQQDRKHEQLKAKKKVVKMLIIVVVIFAICWLP  276 (423)
T ss_pred             CCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccchhchhhHHHHHHHHHHHHHHHHHHHHHHhccC
Confidence                111   22667778899999999999999999999998654                         7999999999


Q ss_pred             HHHHHHHHHhcC-cCCCchhhHHHHHHHHHhccccccchhhhhcccCCccC
Q psy17031        369 YIVFDLLQVYGY-IPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNN  418 (419)
Q Consensus       369 ~~v~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~s~~nP~iY~~~~~~fR~  418 (419)
                      ++.+.++..... ..+.......+....||++.|+|+||+||++.|++||.
T Consensus       277 yh~y~il~~~~~~i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~  327 (423)
T KOG4219|consen  277 YHIYFILNATNPEINRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRG  327 (423)
T ss_pred             hhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHH
Confidence            999999875543 22333334466678999999999999999999999884



>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4219|consensus Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query419
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 3e-09
3oe0_A 499 Crystal Structure Of The Cxcr4 Chemokine Receptor I 3e-07
3odu_A 502 The 2.5 A Structure Of The Cxcr4 Chemokine Receptor 3e-07
3oe6_A 508 Crystal Structure Of The Cxcr4 Chemokine Receptor I 3e-07
3eml_A 488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 3e-07
3eml_A 488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 4e-05
4daj_A 479 Structure Of The M3 Muscarinic Acetylcholine Recept 6e-07
4daj_A 479 Structure Of The M3 Muscarinic Acetylcholine Recept 1e-06
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 7e-07
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 2e-05
4dkl_A 464 Crystal Structure Of The Mu-Opioid Receptor Bound T 8e-07
4eiy_A447 Crystal Structure Of The Chimeric Protein Of A2aar- 1e-06
4eiy_A 447 Crystal Structure Of The Chimeric Protein Of A2aar- 4e-05
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 5e-06
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 3e-05
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 6e-06
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 6e-04
4djh_A 480 Structure Of The Human Kappa Opioid Receptor In Com 1e-05
4djh_A 480 Structure Of The Human Kappa Opioid Receptor In Com 2e-04
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 2e-05
3uon_A 467 Structure Of The Human M2 Muscarinic Acetylcholine 2e-05
3uon_A 467 Structure Of The Human M2 Muscarinic Acetylcholine 2e-04
4ej4_A 461 Structure Of The Delta Opioid Receptor Bound To Nal 4e-05
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 7e-05
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 7e-05
2ks9_A364 Solution Conformation Of Substance P In Water Compl 2e-04
3vw7_A 484 Crystal Structure Of Human Protease-Activated Recep 3e-04
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 7e-04
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure

Iteration: 1

Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust. Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 25/204 (12%) Query: 231 WKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCG--SWRRARWLVGIAW 288 W GN CK V ++ST+ L A+S+DRY AI +P+ + +A+ + W Sbjct: 190 WPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIW 249 Query: 289 LISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQW--QLYMSLVALALFVIPAVXXXX-- 344 ++ ++ +P+A++ ++ +C +E P + ++ + L F++P + Sbjct: 250 ALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCY 309 Query: 345 -----XXXXXXXXXWAKSKLYTF--------------VLCWSPYIVFDLLQVYGYIPRTQ 385 ++ K V CW+P VF L Q G P ++ Sbjct: 310 SLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSE 369 Query: 386 NYIAVATLIQSLAPLNSAANPIIY 409 +A+ +L +NS NPI+Y Sbjct: 370 TAVAILRFCTALGYVNSCLNPILY 393
>pdb|3OE0|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Cyclic Peptide Antagonist Cvx15 Length = 499 Back     alignment and structure
>pdb|3ODU|A Chain A, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In Complex With Small Molecule Antagonist It1t Length = 502 Back     alignment and structure
>pdb|3OE6|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Small Molecule Antagonist It1t In I222 Spacegroup Length = 508 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 Back     alignment and structure
>pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1 (Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom Length = 484 Back     alignment and structure
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query419
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 2e-37
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 3e-18
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 4e-37
4dkl_A 464 MU-type opioid receptor, lysozyme chimera; G-prote 2e-24
4dkl_A 464 MU-type opioid receptor, lysozyme chimera; G-prote 1e-16
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 6e-05
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 6e-04
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 2e-23
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 1e-11
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 4e-22
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-16
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-04
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 6e-19
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 2e-15
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 1e-14
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 3e-15
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 3e-11
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 4e-15
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 7e-13
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 5e-15
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 7e-15
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 4e-12
4eiy_A 447 Adenosine receptor A2A/soluble cytochrome B562 CH; 4e-14
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 6e-14
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 4e-14
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 5e-13
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 7e-13
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 8e-13
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 1e-11
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-07
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query419
4grv_A 510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
3vw7_A 484 Proteinase-activated receptor 1, lysozyme; high re 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 99.98
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 99.97
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 99.97
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 99.97
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 99.97
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 99.97
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 99.97
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 99.96
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 99.64
4grv_A 510 Neurotensin receptor type 1, lysozyme chimera; G-p 99.5
3rze_A 452 Histamine H1 receptor, lysozyme chimera; structura 99.48
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 99.46
3odu_A 502 C-X-C chemokine receptor type 4, lysozyme chimera; 99.45
3uon_A 467 Human M2 muscarinic acetylcholine, receptor T4 LY 99.44
4dkl_A 464 MU-type opioid receptor, lysozyme chimera; G-prote 99.44
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 99.44
3vw7_A 484 Proteinase-activated receptor 1, lysozyme; high re 99.44
3pbl_A 481 D(3) dopamine receptor, lysozyme chimera; structur 99.42
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 99.41
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 99.41
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 99.39
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 99.37
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 99.34
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 99.32
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 99.31
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 99.25
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.14
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 97.72
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 97.53
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 92.66
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 90.25
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 83.22
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=4e-37  Score=316.67  Aligned_cols=193  Identities=23%  Similarity=0.364  Sum_probs=155.2

Q ss_pred             cchHHHHHHHHHHHHHHhhhheeeEEeEeccc---ccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccceee
Q psy17031         93 LNTEQFVILWALFILIVLGNSAVIFTLKFGVK---RRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKV  169 (419)
Q Consensus        93 ~~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~---~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~C~~  169 (419)
                      .+....+++.+++++|++||+++++++.++++   +++++|+|+.|||++|++++++.+|..++.....           
T Consensus        31 ~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~-----------   99 (510)
T 4grv_A           31 SKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWV-----------   99 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTC-----------
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-----------
Confidence            35566778889999999999999988877654   4588999999999999999999999888754321           


Q ss_pred             eeeeceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHHHHH
Q psy17031        170 VRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVT  249 (419)
Q Consensus       170 ~~~~~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~~~~  249 (419)
                                                                                ...|.+|+..|++..++...+.
T Consensus       100 ----------------------------------------------------------~~~w~~g~~~C~~~~~~~~~~~  121 (510)
T 4grv_A          100 ----------------------------------------------------------HHPWAFGDAGCRGYYFLRDACT  121 (510)
T ss_dssp             ----------------------------------------------------------CSSCSSHHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------------------------CCCEEhhHHHHHHHHHHHHHHH
Confidence                                                                      1234566677888888888889


Q ss_pred             HHHHHHHHHHHHhhheeeeccccccc--cchhhhHHHHHHHHHHHHHHHHHHHhheeEeecCC------Cceeeccccch
Q psy17031        250 YSSTYVLVALSIDRYYAIKYPMNFCG--SWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGT------SQCWIEFEKPW  321 (419)
Q Consensus       250 ~~s~~~l~~i~~~Ry~~i~~p~~~~~--t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~------~~C~~~~~~~~  321 (419)
                      .+|.+.+++|++|||.+|++|++|+.  +++++..+++++|++++++++|+++..+.......      ..|...++. .
T Consensus       122 ~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~~~~~~~c~~~~~~-~  200 (510)
T 4grv_A          122 YATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPGGLVCTPIVDT-A  200 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSCCGGGEEEEECSCH-H
T ss_pred             HHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCCCCCcccccccccc-c
Confidence            99999999999999999999999987  88999999999999999999999988766544321      235544433 3


Q ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q psy17031        322 QWQLYMSLVALALFVIPAVIISICYILIITTIWA  355 (419)
Q Consensus       322 ~~~~~~~~~~~~~~~vp~~ii~~~y~~i~~~l~~  355 (419)
                      ....+..+..++.|++|+++|+++|.+|++++|+
T Consensus       201 ~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~  234 (510)
T 4grv_A          201 TVKVVIQVNTFMSFLFPMLVISILNTVIANKLTV  234 (510)
T ss_dssp             HHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHH
Confidence            4456666677888999999999999999998874



>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 419
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 8e-14
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 5e-04
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
 Score = 70.0 bits (170), Expect = 8e-14
 Identities = 43/315 (13%), Positives = 92/315 (29%), Gaps = 46/315 (14%)

Query: 98  FVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSS 157
              ++ L +L    N   ++      K R+ +N+ +++LAVADL +      T +     
Sbjct: 41  AAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLH 100

Query: 158 VTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVL 217
             +  G T C +  +   +    + + LV L+I+RY  +  PM+     +    + V   
Sbjct: 101 GYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGV--- 157

Query: 218 SVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSW 277
                                     + A            +      +           
Sbjct: 158 --------------------AFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEE 197

Query: 278 RRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVI 337
                 V   +++ FI+ + +    + +LV    +   + ++    Q     V   + ++
Sbjct: 198 TNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIM 257

Query: 338 PAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSL 397
                                   F++CW PY                            
Sbjct: 258 VIA---------------------FLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAF--F 294

Query: 398 APLNSAANPIIYCIF 412
           A  ++  NP+IY + 
Sbjct: 295 AKTSAVYNPVIYIMM 309


>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query419
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 99.97
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 99.23
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97  E-value=2.5e-31  Score=256.32  Aligned_cols=253  Identities=20%  Similarity=0.291  Sum_probs=204.5

Q ss_pred             chHHHHHHHHHHHHHHhhhheeeEEeEecccccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccceeeeeee
Q psy17031         94 NTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYS  173 (419)
Q Consensus        94 ~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~C~~~~~~  173 (419)
                      .....+++.+++++|++||+++++++.++|++|++.|+++.|||++|++.++...|..+.....+.|             
T Consensus        37 ~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~~~-------------  103 (348)
T d1u19a_          37 FSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYF-------------  103 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSC-------------
T ss_pred             HHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhccCcc-------------
Confidence            4466677888999999999999999999999999999999999999999999999988776655444             


Q ss_pred             ceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHHHHHHHHH
Q psy17031        174 QAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSST  253 (419)
Q Consensus       174 ~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~~~~~~s~  253 (419)
                                                                                ..++..|+...+....+..++.
T Consensus       104 ----------------------------------------------------------~~~~~~c~~~~~~~~~~~~~s~  125 (348)
T d1u19a_         104 ----------------------------------------------------------VFGPTGCNLEGFFATLGGEIAL  125 (348)
T ss_dssp             ----------------------------------------------------------TTHHHHHHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------------------------ccCchhhhhhhhccccceeeec
Confidence                                                                      4455778888888888999999


Q ss_pred             HHHHHHHHhhheeeeccccccc-cchhhhHHHHHHHHHHHHHHHHHHHhheeEee-cCCCceeeccc---cchhHHHHHH
Q psy17031        254 YVLVALSIDRYYAIKYPMNFCG-SWRRARWLVGIAWLISFILSIPIAVLFHVRLV-QGTSQCWIEFE---KPWQWQLYMS  328 (419)
Q Consensus       254 ~~l~~i~~~Ry~~i~~p~~~~~-t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~-~~~~~C~~~~~---~~~~~~~~~~  328 (419)
                      +.++++++|||.++++|++++. ++++....+..+|..++++..|+......... .+...|.....   .......+..
T Consensus       126 ~~l~~is~~R~~~i~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (348)
T d1u19a_         126 WSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVI  205 (348)
T ss_dssp             HHHHHHHHHHHHHHTCCSSSCCCCHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEEECCCSCCCGGGTHHHHHH
T ss_pred             chhhhhhcccceeeeccccccccccccccccceeeehhhhheecccccccceeccCCcccccccccccccccccchhhHH
Confidence            9999999999999999999887 77888888889999999988887776554433 33444543332   2233455666


Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHhcCc----------------------eEEEEEechhHHHHHHHHHhcCcCCCch
Q psy17031        329 LVALALFVIPAVIISICYILIITTIWAKSK----------------------LYTFVLCWSPYIVFDLLQVYGYIPRTQN  386 (419)
Q Consensus       329 ~~~~~~~~vp~~ii~~~y~~i~~~l~~~~~----------------------~~~f~~cw~P~~v~~~~~~~~~~~~~~~  386 (419)
                      ....+.+++|++++.++|.++.+++||+++                      +++|++||+|+.+..++.......+  .
T Consensus       206 ~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~--~  283 (348)
T d1u19a_         206 YMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSD--F  283 (348)
T ss_dssp             HHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSSCSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSC--C
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhhcccccccchhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCcc--c
Confidence            777888899999999999999999887654                      6999999999999888766653322  2


Q ss_pred             hhHHHHHHHHHhccccccchhhhhcccCCccCC
Q psy17031        387 YIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR  419 (419)
Q Consensus       387 ~~~~~~~~~~l~~~~s~~nP~iY~~~~~~fR~~  419 (419)
                      ......+..+++.+|+++||+||.+++++|||+
T Consensus       284 ~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~  316 (348)
T d1u19a_         284 GPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNC  316 (348)
T ss_dssp             CHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHH
Confidence            334566778899999999999999999999974



>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure